Bodal Chemicals Limited carries a market capitalization of 7.84B, placing it among publicly traded companies globally. Its enterprise value stands at 13.95B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.84B |
| Enterprise Value | 13.95B |
Bodal Chemicals Limited currently has 125.94M shares outstanding.
| Shares Outstanding | 125.94M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Bodal Chemicals Limited trades at a trailing price-to-earnings ratio of 13.37. The price-to-sales ratio is 0.32, and the price-to-book ratio stands at 25.39.
| PE Ratio | 13.37 |
| PS Ratio | 0.32 |
| PB Ratio | 25.39 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Bodal Chemicals Limited trades at an EV/EBITDA multiple of 14.15 and an EV/FCF ratio of 20.12. The EV/Sales ratio of 0.69 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 14.15 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.69 |
| EV / EBITDA | 14.15 |
| EV / EBIT | 14.15 |
| EV / FCF | 20.12 |
Bodal Chemicals Limited maintains a current ratio of 1.23, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 70.25, indicating elevated leverage, while an interest coverage ratio of 1.25 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.23 |
| Quick Ratio | 0.08 |
| Debt / Equity | 70.25 |
| Debt / EBITDA | 8.25 |
| Interest Coverage | 1.25 |
Bodal Chemicals Limited posts a return on equity of 12.17 and a return on invested capital of 4.35.
| Return on Equity (ROE) | 12.17 |
| Return on Assets (ROA) | 2.03 |
| Return on Invested Capital (ROIC) | 4.35 |
| Return on Capital Employed (ROCE) | 9.34 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 3.36 |
Over the trailing twelve months, Bodal Chemicals Limited has paid 65.49M in income taxes, reflecting an effective tax rate of 12.04.
| Income Tax | 65.49M |
| Effective Tax Rate | 12.04 |
Bodal Chemicals Limited's stock has declined approximately -19.15281% over the past 52 weeks. The 50-day moving average sits at 68.94, while the 200-day moving average is 58.23.
| Beta (5Y) | N/A |
| 52-Week Price Change | -19.15281% |
| 50-Day Moving Average | 68.94 |
| 200-Day Moving Average | 58.23 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Bodal Chemicals Limited generated 20.12B in revenue and converted that into 478.28M in net income, yielding earnings per share of 3.83. EBITDA reached 985.62M, while operating income came in at 985.62M.
| Revenue | 20.12B |
| Gross Profit | 9.02B |
| Operating Income | 985.62M |
| Pretax Income | 543.77M |
| Net Income | 478.28M |
| EBITDA | 985.62M |
| EBIT | 985.62M |
| Earnings Per Share (EPS) | 3.83 |
Bodal Chemicals Limited holds 579.69M in cash and equivalents against 8.13B in total debt, resulting in a net debt position of 7.83B. Total book value stands at 251.89M, with working capital of 1.73B providing operational flexibility.
| Cash & Cash Equivalents | 579.69M |
| Total Debt | 8.13B |
| Net Debt | 7.83B |
| Equity (Book Value) | 251.89M |
| Book Value Per Share | 2.02 |
| Working Capital | 1.73B |
Bodal Chemicals Limited operates with a gross margin of 44.83, reflecting its pricing power and cost economics. The operating margin of 4.90 and net profit margin of 2.38 provide insight into operational efficiency.
| Gross Margin | 44.83 |
| Operating Margin | 4.90 |
| Pretax Margin | 2.70 |
| Profit Margin | 2.38 |
| EBITDA Margin | 4.90 |
Bodal Chemicals Limited posts an Altman Z-Score of 1.41, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.41 |